Accéder au contenu
Merck

Cardiovascular baroreceptor activity and selective inhibition of monoamine oxidase.

European journal of pharmacology (2012-04-03)
Orit Bar-Am, Aviva Gross, Rachel Friedman, John P M Finberg
RÉSUMÉ

Cardiovascular baroreceptor responsiveness of conscious rats treated with selective inhibitors of monoamine oxidase (MAO) types A and B was determined by measurement of blood pressure (BP) and heart rate (HR) responses to intravenous injection of phenylephrine and sodium nitroprusside. Treatment with selegiline (1 or 5 mg/kg p.o. daily for 7 days) did not significantly modify resting levels of BP and HR, lower or upper HR plateau levels, or HR/BP gain. Treatment with clorgyline (2 mg/kg p.o. daily for 7 days) increased HR/BP gain but also did not modify resting BP or HR, or lower and upper plateau levels of HR. The results are compatible with an effect of MAO-A inhibition to modify monoamine levels in medullary areas participating in CNS control of blood pressure.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
R-(−)-Deprenyl hydrochloride, powder, ≥98% (HPLC)
Selegiline hydrochloride, European Pharmacopoeia (EP) Reference Standard